Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CYTK · against 1,216 other Healthcare companies
Ranked #263 of 1,217 · scores higher than 78% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including CYTK · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | CYTK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -21.1% | 6.1% | 9% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 89.5% | 5.8% | 95% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 263 | 6.5B TWD (≈$200M) | 78 | 76 | |
| 263 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 1.8B USD |
| 78 |
| 63 |
| 263 | 457M USD | 78 | 58 |
| 263 | 326M EUR (≈$359M) | 78 | 75 |
| 263 | 8.7B USD | 78 | 26 |
| 263 | 31.3B USD | 78 | 63 |
| 263 | 27.5B EUR (≈$30.2B) | 78 | 60 |
| 263 | 549M EUR (≈$604M) | 78 | 56 |
| 263 | 126.5B USD | 78 | 56 |